CDSCO seeks to end brand name extensions across unrelated drugs
India's drug regulator has announced a proposal to limit the use of identical brand names for various medications, aiming to improve patient safety and reduce consumer confusion. The Central Drugs Standard Control Organisation is currently seeking public feedback on this initiative, which may require pharmaceutical companies to rethink their branding approaches for different products, ensuring brand names appropriately reflect the unique characteristics of each medication.
